In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 28th, 2004 | 15 | No |
(+)-ethotoin; (5S)-3-ethyl-5-phenylhydantoin; (S)-(+)-ethotoin
(+-)-3-Ethyl-5-phenylhydantoin
1-Ethyl-2,5-dioxo-4-phenylimidazolidine
2,4-Imidazolidinedione, 3-ethyl-5-phenyl-
2,4-Imidazolidinedione, 3-ethyl-5-phenyl-, (+-)-
3-Ethyl-5-phenyl-2,4-imidazolidinedione
3-Ethyl-5-phenylimidazolidin-2,4-dione
3-ethyl-5-phenylimidazolidine-2,4-dione
5-24-08-00005 (Beilstein Handbook Reference)
86-35-1; Accenon (TN); D00708; Ethotoin (JAN/USP/INN); Peganone (TN)
ethotoin; ethotoine; ethotoinum; etotoina
Ethotoine [INN-French];Ethotoinum [INN-Latin];Etotoina [INN-Spanish]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.13 | 4.16 | -7.82 | 1 | 4 | 0 | 49 | 204.229 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.38e+00 g/l | DrugBank-approved |
Therapy | anticonvulsant | SMDC Pharmakon |
PUBCHEM_PATENT_ID | EP0110955A1; EP0110955B1; EP0156382A2; EP0233932A1; EP0246809A2; EP0246809B1; EP0273890A1; EP0302714A2; EP0326278A1; EP0326278B1; EP0327766A2; EP0327766B1; EP0335545A2; EP0335545B2; EP0411629A2; EP0411629B1; EP0416575A3; EP0450094A1; EP0450094B1; EP045283 | IBM Patent Data |